FI56535C - Vid framstaellning av 3-cefalosporinantibiotika saosom mellanprodukter anvaendbara 7-skyddad-amino- 2-cefalosporansyraestrar - Google Patents

Vid framstaellning av 3-cefalosporinantibiotika saosom mellanprodukter anvaendbara 7-skyddad-amino- 2-cefalosporansyraestrar Download PDF

Info

Publication number
FI56535C
FI56535C FI326/69A FI32669A FI56535C FI 56535 C FI56535 C FI 56535C FI 326/69 A FI326/69 A FI 326/69A FI 32669 A FI32669 A FI 32669A FI 56535 C FI56535 C FI 56535C
Authority
FI
Finland
Prior art keywords
cephem
methyl
carboxylate
ester
phenoxyacetamido
Prior art date
Application number
FI326/69A
Other languages
English (en)
Finnish (fi)
Other versions
FI56535B (fi
Inventor
John Alan Webber
Earle Marvin Van Heyningen
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority to FI6474A priority Critical patent/FI55665C/fi
Priority to FI6374A priority patent/FI55666C/fi
Publication of FI56535B publication Critical patent/FI56535B/fi
Application granted granted Critical
Publication of FI56535C publication Critical patent/FI56535C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/60Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 3 and 4
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
FI326/69A 1968-02-07 1969-02-04 Vid framstaellning av 3-cefalosporinantibiotika saosom mellanprodukter anvaendbara 7-skyddad-amino- 2-cefalosporansyraestrar FI56535C (fi)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI6474A FI55665C (fi) 1968-02-07 1974-01-10 Nytt foerfarande foer framstaellning av 3-cefalosporinfoereningar
FI6374A FI55666C (fi) 1968-02-07 1974-01-10 Vid framstaellning av 3-cefalosporinantibiotika saosom mellanprodukter anvaendbara 2-3-brommetylcefalosporinderivat

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US70352368A 1968-02-07 1968-02-07
US70352368 1968-02-07
US79084269A 1969-01-13 1969-01-13
US79088669A 1969-01-13 1969-01-13
US79088669 1969-01-13
US79084269 1969-01-13

Publications (2)

Publication Number Publication Date
FI56535B FI56535B (fi) 1979-10-31
FI56535C true FI56535C (fi) 1980-02-11

Family

ID=27418758

Family Applications (1)

Application Number Title Priority Date Filing Date
FI326/69A FI56535C (fi) 1968-02-07 1969-02-04 Vid framstaellning av 3-cefalosporinantibiotika saosom mellanprodukter anvaendbara 7-skyddad-amino- 2-cefalosporansyraestrar

Country Status (11)

Country Link
JP (3) JPS524558B1 (ja)
BE (1) BE728053A (ja)
CH (1) CH534694A (ja)
DK (1) DK140726B (ja)
FI (1) FI56535C (ja)
FR (3) FR2001491B1 (ja)
GB (2) GB1265332A (ja)
IL (2) IL40447A (ja)
LU (1) LU57932A1 (ja)
NL (1) NL173407C (ja)
SE (3) SE384511B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2132883A1 (de) * 1970-07-08 1972-01-13 Ciba Geigy Ag Cephemverbindungen
JPS53164082U (ja) * 1977-05-31 1978-12-22
JPS5899787U (ja) * 1981-12-28 1983-07-07 奥野電器株式会社 ランプ用ソケツト
EP0300546B1 (en) * 1987-07-10 1995-08-09 Gist-Brocades N.V. Process for the preparation of cephem compounds and cephalosporin derivatives

Also Published As

Publication number Publication date
NL173407C (nl) 1984-01-16
JPS4924076B1 (ja) 1974-06-20
FI56535B (fi) 1979-10-31
JPS524559B1 (ja) 1977-02-04
FR2085656B1 (ja) 1974-08-23
FR2001491B1 (ja) 1973-07-13
DK140726C (ja) 1980-03-31
JPS524558B1 (ja) 1977-02-04
FR2085656A1 (ja) 1971-12-31
IL41553A (en) 1976-02-29
SE7512818L (sv) 1975-11-14
CH534694A (de) 1973-03-15
LU57932A1 (ja) 1969-09-17
FR2095486A5 (ja) 1972-02-11
NL173407B (nl) 1983-08-16
GB1265333A (ja) 1972-03-01
GB1265332A (ja) 1972-03-01
IL40447A (en) 1976-02-29
FR2001491A1 (ja) 1969-09-26
SE384511B (sv) 1976-05-10
SE407064B (sv) 1979-03-12
NL6902013A (ja) 1969-08-11
DK140726B (da) 1979-11-05
BE728053A (ja) 1969-08-07
SE418616B (sv) 1981-06-15

Similar Documents

Publication Publication Date Title
FI56686C (fi) Foerfarande foer framstaellning av 7-aminocefalosporansyraderivat med antibiotisk verkan
DE3152935C2 (ja)
EP1546155B1 (en) Intermediate cefdinir salts
LU84717A1 (fr) Nouveaux derives de cephalosporine,leur procede de production et composition pharmaceutique les contenant
FI57419B (fi) Foerfarande foer framstaellning av 3-exometylencefamfoereningar
IE49657B1 (en) Cephalosporin derivatives
HU215925B (hu) Eljárás cefemszármazékok előállítására
JPH07503474A (ja) 3−セフェム−4−カルボン酸誘導体の精製方法
FI56535C (fi) Vid framstaellning av 3-cefalosporinantibiotika saosom mellanprodukter anvaendbara 7-skyddad-amino- 2-cefalosporansyraestrar
US3780033A (en) Process for preparing cephalosporin compounds
US5389627A (en) Cephem compounds
Bohme et al. 6-Alkylpenicillins and 7-alkylcephalosporins
JPS6133833B2 (ja)
FI63240C (fi) Analogifoerfarande foer framstaellning av antibakteriella 3-klorcefalosporinderivat
RU2091384C1 (ru) Производные цефалоспорина и их фармакологически приемлемые нетоксичные соли, физиологически гидролизуемые сложные эфиры, син-изомеры и оптические изомеры и способ их получения
CA1114808A (en) Derivatives of 7-¬substituted oxyiminoacetamido| cephalosporins
SU543353A3 (ru) Способ получени производных 7-монохлорацетамидо-3-дезацетоксицефалоспорановой кислоты
US4308267A (en) 7-[2-Alkoxyimino-2-(amino-thiazole)acetamido]-3-[1-(sulfaminoalkly)tetrazolthiomethyl]cephalosporins
US4148996A (en) 3,7-Disubstituted cephalosporins
JPH04112891A (ja) 新規オキシム誘導体及び該誘導体を含有する抗菌剤
SU1114339A3 (ru) Способ получени 3-тиовинилцефалоспоринов или их солей
FI75166B (fi) Foerbaettrat foerfarande foer framstaellning av 6- -substituerad penicillanoyloximetyl-penicillanat- 1,1-dioxid.
KR970001530B1 (ko) 화합물의 제조 방법
KR830000341B1 (ko) 세팔로스포린 유도체의 제법
FI59104C (fi) Saosom mellanprodukt vid framstaellning av 3-desacetoxi-cefalosporiner anvaendbar med 3-exometylen substituerad cefalosporinfoerening